Alkermes Plc Revenue per Employee (ALKS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Alkermes Plc   (NASDAQ: ALKS)
 

Alkermes Plc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 26.97% in the second quarter 2026, year on year to cumulative value of $1,668 million, Alkermes Plc 's revenue per employee grew on a trailing twelve months basis to $ 813,489. The productivity of Alkermes Plc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 111 other companies have achieved higher revenue per employee. While Alkermes Plc 's total ranking has deteriorated compared to the previous quarter from 459 to 1105. Alkermes Plc has 2,050 employees.


What is Sales per Employee Ratio?







ALKS Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 26.97 % 28.19 % -10.57 % 4.24 % -2.12 %
Sales per Employee (TTM) $ 813,489 762,098 719,951 742,116 734,291
ALKS's Total Ranking # 1105 # 459 # 857 # 192 # 315
Seq. Revenue Change 26.24 % 2.18 % -2.45 % 0.9 % 27.45 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 77
Healthcare Sector # 112
Overall Market # 1105

Revenue per Employee Statistics
High Average Low
$ 842,040 $ 528,711 $ 281,836
(Mar 31 2024)   (Sep 30 2013)



Financial Statements
Alkermes Plc 's Revenue MRQ $ 496 Millions Visit ALKS's Income Statement
Alkermes Plc 's Revenues TTM $ 1,668 Millions Visit ALKS's aggregate revenue growth
What are ALKS's Sales? Visit ALKS's Sales by Segment




Other Ratios
Alkermes Plc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ALKS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ALKS's Competitors
Revenue per Employee for ALKS's Suppliers
Revenue per Employee for ALKS's Customers

You may also want to know
ALKS's Sales Growth Rates ALKS's Pe Price to earnings ratio ALKS's Receivables Turnover Ratio ALKS's Stock Quote
ALKS's Net Income Growth Rates ALKS's Ps Price to Sales ratio ALKS's Sales per Employee ALKS's Asset Turnover Ratio
ALKS's Net Margin ALKS's Pb Price to Book ratio ALKS's Financial Strength Ratios ALKS's Dividend Payout Ratio
Date modified: 2026-09-26T06:58:04+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Madrigal Pharmaceuticals Inc   1,403,213.11 $ 1,283.940  Million 915 
Indivior Pharmaceuticals Inc   1,333,000.00 $ 1,333.000  Million 1,000 
Arcutis Biotherapeutics Inc   1,310,680.79 $ 463.981  Million 354 
Lantheus Holdings Inc   1,303,724.22 $ 1,555.343  Million 1,193 
Cue Biopharma Inc   1,298,413.79 $ 37.654  Million 29 
Puma Biotechnology Inc   1,291,865.92 $ 231.244  Million 179 
Arvinas Inc   1,287,398.37 $ 316.700  Million 246 
Supernus Pharmaceuticals inc   1,273,677.91 $ 830.438  Million 652 
Travere Therapeutics Inc   1,189,798.79 $ 591.330  Million 497 
Heron Therapeutics Inc   1,183,648.44 $ 151.507  Million 128 
Journey Medical Corp  1,175,534.48 $ 68.181  Million 58 
Theravance Biopharma inc   1,159,011.11 $ 104.311  Million 90 
Corcept Therapeutics Inc  1,138,100.00 $ 830.813  Million 730 
Abbvie Inc   1,129,578.95 $ 64,386.000  Million 57,000 
Akebia Therapeutics Inc   1,129,175.26 $ 219.060  Million 194 
Siga Technologies Inc  1,095,079.92 $ 53.659  Million 49 
Biomarin Pharmaceutical Inc  1,057,626.20 $ 3,406.614  Million 3,221 
Hims and Hers Health Inc   1,055,894.35 $ 2,578.494  Million 2,442 
Assembly Biosciences Inc   1,025,273.97 $ 74.845  Million 73 
Sanara Medtech Inc   1,019,592.91 $ 110.116  Million 108 
Ptc Therapeutics inc   1,017,915.24 $ 1,008.754  Million 991 
Ani Pharmaceuticals Inc  1,008,638.14 $ 978.379  Million 970 
Regeneron Pharmaceuticals Inc   1,008,092.15 $ 15,534.700  Million 15,410 
Coya Therapeutics Inc   1,002,393.13 $ 8.019  Million 8 
Meiragtx Holdings Plc  986,354.84 $ 397.501  Million 403 
Evolus Inc   949,440.12 $ 317.113  Million 334 
Arrowhead Pharmaceuticals Inc   941,624.47 $ 669.495  Million 711 
Scilex Holding Company  929,647.06 $ 31.608  Million 34 
Ardelyx inc   922,073.62 $ 450.894  Million 489 
The Oncology Institute Inc   916,137.29 $ 587.244  Million 641 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.